NCT04750655View on ClinicalTrials.gov

Antibiotic Resistance In Eye Surgeries

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

August 10, 2023

Study Completion Date

August 31, 2023

Conditions
Antibiotic ResistanceOcular Surface MicrobiomeGut Resistome
Interventions
DRUG

Moxifloxacin (Topical)

We are using moxifloxacin as indicated and as intended for use as an antibiotic during surgery. Frequency of postoperative antibiotics dependent on group randomization.

Trial Locations (1)

94158

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04750655 - Antibiotic Resistance In Eye Surgeries | Biotech Hunter | Biotech Hunter